| Document |
Document Title |
|
JPS6352639B2 |
|
|
JPS6352638B2 |
|
|
JPS63246395A |
NEW MATERIAL:A compound expressed by formula I (R1 is protecting group of diol; R2 is protecting group of ketone). EXAMPLE: (2R,3S)-6,6-Ethylenedioxy-2,3-isopropylidenedioxy-5α-pregna
n-20-one. USE: A raw material for synthesizing brass...
|
|
JPS6351157B2 |
|
|
JPS63502436A |
PCT No. PCT/EP87/00004 Sec. 371 Date Oct. 29, 1987 Sec. 102(e) Date Oct. 29, 1987 PCT Filed Jan. 7, 1987 PCT Pub. No. WO87/04167 PCT Pub. Date Jul. 16, 1987. I Compounds I (either R1=OH, C1-C4 alkoxy and R2=H, C1-C4 alkyl, or R1+R2=a che...
|
|
JPS63215695A |
NEW MATERIAL:A compound expressed by formula I (R1 and R2 are H or 1W6C alkyl; R3 is H, acetyl, 1W6C alkyl, 2W5C alkoxycarbonyl or 1W3C alkylthio; X is H or halogen; the dotted line, as necessary, indicates double bond). EXAMPLE: Desonid...
|
|
JPS63502180A |
PCT No. PCT/EP87/00005 Sec. 371 Date Oct. 29, 1987 Sec. 102(e) Date Oct. 29, 1987 PCT Filed Jan. 7, 1987 PCT Pub. No. WO87/04168 PCT Pub. Date Jul. 16, 1987. I Compounds I [R1=H or C1-C3 alkyl, R2=an (alkyl-substituted) aminodeoxy or ami...
|
|
JPS63201197A |
11 beta -substituted steroids of the formula wherein A and B together represent a second bond between the 6-position and 7-position carbon atoms, or, respectively, are each H; X is O, two H atoms or hydroximino; Z is the residue of a pen...
|
|
JPS6337800B2 |
A process for the synthesis of 1 alpha ,3 beta -dihydroxy- DELTA 5-steroids from steroids such as 1 alpha ,2 alpha -epoxy-cholesta-4,6-dien-3-one, which is reacted with lithium in liquid ammonia in the absence of a proton donator and sub...
|
|
JPS6337085B2 |
|
|
JPS6337120B2 |
Compounds of the formula (I) wherein R1 represents a fluoro-, chloro- or bromo-methyl group or a 2'-fluoroethyl group, R2 represents a group COR6 where R6 is a C1-3 alkyl group or OR2 and R3 together form a 16 alpha ,17 alpha -isopropyli...
|
|
JPS63156725A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS63101397A |
The invention relates to new aromatase inhibitor agents having the general formula (I) wherein R1 is hydrogen or a group = CHR3 wherein R3 is hydrogen or C1-C6 alkyl; the symbol ----- indicates the presence of a single or double bond in ...
|
|
JPS6383095A |
The invention relates to 4-substituted 6-alkylidenandrostene-3,17-dione derivatives of the following formula wherein each of R1, R2 and R3 is, independently, hydrogen or C1-C6 alkyl; R4 is hydrogen or fluorine; (x) represents a single or...
|
|
JPS6360995A |
NEW MATERIAL:A compound expressed by formula I [R1 represents 1W6C alkyl, 5W6C cycloalkyl, phenyl, (substituted) benzyl or 2W6C alkanoyl; R2 represents H; R3 represents CH3 or links with R2 to form lower alkylidenedioxy; X represents hal...
|
|
JPS6354394A |
NEW MATERIAL:A compound expressed by formula I (R2 is H, OH or trifluoroacetoxy when R1 is methyl; R2 and R3 together form π bond; R1 and R2 together form methylene; R3 is H; R4 and R5 are H or R4 and R5 together form π bond; R6 is H o...
|
|
JPS6310160B2 |
PCT No. PCT/JP82/00384 Sec. 371 Date Apr. 20, 1983 Sec. 102(e) Date Apr. 20, 1983 PCT Filed Sep. 24, 1982 PCT Pub. No. WO83/01065 PCT Pub. Date Mar. 31, 1983.Novel steroid saponin compounds (XR-1) and (XR-2) are extracted from Solanam ac...
|
|
JPS6310159B2 |
3-enol ethers of 11 beta -hydroxy- DELTA 4-pregnene-3-ones are prepared by reacting triethylorthoacetate with an 11 beta -hydroxy- DELTA 4-pregnene-3-one in a solvent which is at least 40% by weight or more ethanol and 60% by weight or l...
|
|
JPS636559B2 |
Novel DELTA 4-androstenes of the formula I' wherein R1 is alkyl of 1 to 3 carbon atoms, R' is an acyl of an organic carboxylic acid or carbonic acid of 1 to 18 carbon atoms, R2 is selected from the group consisting of alkyl of 1 to 12 ca...
|
|
JPS6322022A |
A method of regulating fertility in cattle which comprises administering to a normally cycling cow in the early luteal phase of the cycle an amount of epostane sufficient to induce estrus.
|
|
JPS6314798A |
NEW MATERIAL:A compound of formula I [formula II is formula IIIWV (R4 is 1W4C alkyl or benbyl; R5 is 1W4C alkyl, 1W4C alkoxy 1W2C alkyl or tetrahydropyranyl); R1 is 1W3C alkyl; R2 is H or 1W2C alkyl; R3 is H, acetyl, propionyl, benzyl, b...
|
|
JPS631320B2 |
Novel 11 beta -substituted- DELTA 9-ene-5 alpha -ols of the formula I wherein K is a blocked ketone in the form of a ketal, thio-ketal or methyloxime, X is a pentagonal or hexagonal ring optionally substituted, R1 is selected from the gr...
|
|
JPS63440B2 |
|
|
JPS6261599B2 |
The invention refers to compounds having anti-inflammatory activity, characterized by the formula (I) in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents at the carbon ato...
|
|
JPS6258360B2 |
A unique crystalline form of flunisolide is prepared by crystallizing flunisolide from a solution thereof in an alkanol of three or four carbon atoms, e.g. n-butanol, containing 0.2 to 5%, preferably 1.0 to 4.0% by volume water.
|
|
JPS6257638B2 |
Novel 11 beta -substituted- DELTA 1,3,5(10)-estratrienes of the formula I wherein R1 is selected from the group consisting of optionally substituted unsaturated alkyl of 2 to 8 carbon atoms, optionally substituted aryl of 6 to 12 carbon ...
|
|
JPS6252759B2 |
What is disclosed are steroid-21-halogeno-17-(alkyl carbonates), useful as medicaments for the treatment of inflammatory dermatoses, and a method for making them.
|
|
JPS62242696A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS6247878B2 |
Novel steroids of the formula I wherein R1 is linear or branched alkyl of 1 to 12 carbon atoms, unsaturated alkyl of 2 to 8 carbon atoms optionally substituted, optionally substituted aryl of 6 to 12 carbon atoms, optionally substituted ...
|
|
JPS62230726A |
PURPOSE: A remedy, constituted of a fat emulsion containing a steroid having immunosuppressive action, useful for treating autoimmune diseases, e.g. chronic rheumarthritis, systemic lupus erythematosus, etc., having improved activity sus...
|
|
JPS6247880B2 |
1525181 Particular crystalline form of fluorisolide SYNTEX (USA) Inc 26 May 1976 [27 May 1975 (2)] 21936/76 Heading C2U [Also in Division A5] A novel crystalline form of 6α - fluoro - 11#,21- dihydroxy - 16α,17α - isopropylidenedioxyp...
|
|
JPS6246558B2 |
|
|
JPS6246557B2 |
New 16,17-pyrazolino- and 16,17-isopyrazolino-1,4-pregnadiene-derivatives have been prepared, useful as antiinflammatory agents on topical and/or systemic administration. An analogy process for the preparation of 16,17-pyrazolino-1,4-pre...
|
|
JPS6245880B2 |
|
|
JPS6244526B2 |
PURPOSE:A recovery agent for the titled symptom comprising crude saponin of a medicinal ginseng as an active constituent. CONSTITUTION:A recovery agent for stress symtom accompanied by autonomic imbalance which is a cause for gastroenter...
|
|
JPS6244560B2 |
This specification relates to the production of 9.alpha.-halo-11.beta.-hydroxy-corticosteroids, to intermediates used in the production of such steroids, and to the production of such intermediates themselves. The specification is partic...
|
|
JPS6241719B2 |
Novel steroids of the formula WHEREIN X is selected from the group consisting of =O and, OH ANGLE , H Y is selected from the group consisting of hydrogen and -OH and when R1 is -(CH2)a-COOH in which a is equal to 2n + 3 and n is 0, 1 or ...
|
|
JPS62190195A |
10 beta -Alkynyl-4,9(11)-estradiene derivatives of formula (I): wherein R is hydrogen, C1-C4 alkyl or halogen; n is zero, 1 or 2; R1 and R2 are both hydrogen, or R1 and R2, taken together, form an oxo group or a methylene group; the symb...
|
|
JPS62190196A |
10 beta -Halo-alkynyl estrene derivatives of formula (I): wherein X is halogen; n is zero, 1 or 2; Y is an oxo group or a methylene group; one of R1 and R2 is hydrogen and the other is hydrogen, C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkyny...
|
|
JPS62174067A |
1. Resorufin derivatives of the general formulae Ia and Ib see diagramm : EP0209875,P26,F3 in which R**1 , R**2 , R**3 , R**4 and R**5 , which in each case can be the same or different, signify hydrogen, halogen, a carboxyl, carboxamido,...
|
|
JPS62174066A |
1. Resorufin derivatives of the general formulae Ia and Ib see diagramm : EP0209875,P26,F3 in which R**1 , R**2 , R**3 , R**4 and R**5 , which in each case can be the same or different, signify hydrogen, halogen, a carboxyl, carboxamido,...
|
|
JPS6234040B2 |
Corticoid-21-sulphopropionate derivs. of formula (I) and their salts with pharmaceutically-acceptable bases are new: (St = steroid residue of an antiinflammatory corticoid; esp. it has formula (X = H, Cl, F or CH3; Y = H, F or Cl; Z = ox...
|
|
JPS62158300A |
6-Substituted 10 beta -alkynylestrene derivatives of formula (I): wherein X is hydrogen, C1-C4 alkyl or halogen; n is zero, 1 or 2; Y is an oxo group or a methylene group; the symbol @ indicates a single bond or a double bond; R1 is halo...
|
|
JPS62155294A |
1. m¢ethyl-15alpha-alkylandrosta-1,4-dienes-3,17-diones of the general formula I see diagramm : EP0225272,P12,F1 in which R15 is an alkyl group of 1 to 4 carbon atoms, which may be substituted in the 1 and/or 2 position by a hydroxy or ...
|
|
JPS6230200B2 |
Novel steroids of the formula I wherein R1 is selected from the group consisting of hydrogen and acyl of an organic carboxylic acid of 1 to 18 carbon atoms, R2 is selected from the group consisting of optionally substituted aryl of 6 to ...
|
|
JPS62142197A |
This specification relates to the production of 9.alpha.-halo-11.beta.-hydroxy-corticosteroids, to intermediates used in the production of such steroids, and to the production of such intermediates themselves. The specification is partic...
|
|
JPS6228159B2 |
|
|
JPS6228157B2 |
New and useful steroids of the pregnane series and compositions therefor are disclosed of the formula: (I) wherein R1 is selected from the group consisting of H, F, OH, and OR2, and R2 is carbacyl of one to eighteen carbon atoms, which s...
|
|
JPS6228160B2 |
PROCESS FOR THE PRODUCTION OF 17-ESTERS OF CLOBETASOL This invention relates to an improved process for the preparation of 17-esters of Clobetasol having the formula II which consists in treatment of 9.beta.,11.beta.-epoxy-16.beta.-methy...
|
|
JPS6227077B2 |
6,6-Ethylenedioxy-22R-hydroxy-2R,3S-isopropylidenedioxy-5 alpha -cholest-23-yne, useful as an intermediate for the synthesis of brassinolide.
|
